When all is said and done Biotron have managed to tick all the boxes with BIT225....They have moved a little slowly for me and I would have liked to see a bigger raising to get things moving.
She has managed to maintain a reasonable trading range for the majority of the last 5 years.
Ultimately a 2 for 9 raising for $4mil is sound(if not conservative)at this point.
The 60 patient trial will add some weight to BIT225.
This is the spec end of the market,so no use getting jittery now when they are on the cusp of BIT225's largest and
most significant trial.
To those moving on best wishes.
To those staying,Hang on and Good Luck.
When all is said and done Biotron have managed to tick all the...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
